BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35352633)

  • 41. [Surgical therapy of pulmonary metastases of colorectal cancer--ten-year results].
    Vodicka J; Spidlen V; Simánek V; Safránek J; Treska V; Skalický T; Sutnar A; Fichtl J; Mukensnabl P
    Rozhl Chir; 2012 Feb; 91(2):81-6. PubMed ID: 22746086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
    Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK
    Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors.
    Sucandy I; Cheek S; Golas BJ; Tsung A; Geller DA; Marsh JW
    HPB (Oxford); 2016 Sep; 18(9):756-63. PubMed ID: 27593593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.
    Perry JF; Charlton B; Koorey DJ; Waugh RC; Gallagher PJ; Crawford MD; Verran DJ; McCaughan GW; Strasser SI
    Liver Int; 2007 Nov; 27(9):1240-8. PubMed ID: 17919236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.
    Hattori N; Kanemitsu Y; Komori K; Shimizu Y; Sano T; Senda Y; Mitsudomi T; Fukui T
    World J Surg; 2013 Jun; 37(6):1315-21. PubMed ID: 23435701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
    Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
    Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
    Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
    Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
    Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
    Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.
    Kobayashi A; Morioka D; Matsumoto C; Miura Y; Miura M
    J Med Case Rep; 2016 May; 10(1):136. PubMed ID: 27234582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
    Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA
    Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5-8 cm.
    Dai WC; Cheung TT; Chok KS; Chan AC; Sharr WW; Tsang SH; Yuen WK; Chan SC; Fan ST; Lo CM; Poon RT
    HPB (Oxford); 2015 Mar; 17(3):226-31. PubMed ID: 25284590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.
    Gonzalez M; Robert JH; Halkic N; Mentha G; Roth A; Perneger T; Ris HB; Gervaz P
    World J Surg; 2012 Feb; 36(2):386-91. PubMed ID: 22167262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis: A Matched Cohort Study.
    McPhail MJW; Khorsandi SE; Abbott L; Al-Kadhimi G; Kane P; Karani J; O'Grady J; Heaton N; Bomford A; Suddle A
    Am J Clin Oncol; 2019 Dec; 42(12):918-923. PubMed ID: 31436748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
    Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
    AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.